PK/PD Investigation of Modufolin (Arfolitixorin) in Plasma, Tumor and Adjacent Mucosa Adjacent Mucosa in Patients With Colon Cancer

NCT01681472 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Colonic Neoplasms

Interventions

DRUG: 6R-MTHF (arfolitixorin) 200 mg/m2
DRUG: Levoleucovorin 200 mg/m2
DRUG: 6R-MTHF (arfolitixorin) 60 mg/m2
DRUG: Levoleucovorin 60 mg/m2

Sponsor

Isofol Medical AB